PHARMA GRADE MAGNESIUM TRISILICATE MARKET ANALYSIS

Pharma Grade Magnesium Trisilicate Market by Product Type (heavy and Light), by Application (Pharmaceuticals, Cosmetics, Food, and Industrial), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Sep 2024
Code : CMI2309
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Pharma Grade Magnesium Trisilicate Market Driver

Safe use of magnesium trisilicate as an antacid medication for pregnant and lactating mothers suffering from acidity is expected to propel growth of pharma grade magnesium trisilicate in global market over the forecast period. For instance, National Health Service in June 2014, stated that magnesium containing antacids are safe to use by pregnant and lactating mothers. Their use for dyspepsia and gastro-esophageal reflux is considered to be compatible with breastfeeding. Also, No adverse effects in breastfeeding infants have been reported.

Pharma grade Magnesium Trisilicate Market Restraint

Prohibitions on import of pharma grade magnesium trisilicate in different countries are expected to restrain growth of the pharma grade magnesium trisilicate market over the forecast period. For instance, in February 2017, Nigeria Customs Service (NCS) prohibited import of medicines included under Headings 3003 and 3004, which consists magnesium trisilicate tablets and suspensions as one of the product.